Abstract 4371297: The effect of Remote Ischemic Conditioning in Acute Ischemic Stroke Treated with Intravenous Thrombolysis, systematic review and meta analysis

Y Yousif Kurmasha (College of Medicine, university of Kufa, Najaf, Iraq) M Mohamed wagdy K khadeeja Hamzah (Baghdad University AIkindy College, Baghdad , Iraq) Y Yasser Almealawy (Faculty of Medicine, University of Kufa, Kufa, Iraq) M Mohammedsadeq A. Shweliya (Baghdad University, Baghdad , Iraq) A Abdulrahman Raad Abdulkareem Al-waeli (al-karkh General hospital, Baghdad, Iraq) A Abubaker Alghazal (Faculty of medicine, University of Benghazi, Benghazi, Libya) M Mohamed Morshed (The Faculty of Medicine Mansoura University, Mansoura, Egypt) Z Zahraa Ali (Baghdad University, Baghdad , Iraq) A Ali Saad Al-Shammari (University of Baghdad, Baghdad, Iraq) M Mohammed Kirmasha (Tehran university of medical science, Tehran, Iran (the Islamic Republic of))

Abstract

Background: Intravenous thrombolysis (IVT) improves outcomes in acute ischemic stroke (AIS), but many patients still do not achieve full recovery. Remote ischemic conditioning (RIC) repetitive brief limb ischemia followed by reperfusion, is a low cost, noninvasive strategy that may activate systematic neuroprotective pathways to reduce ischemic reperfusion injury. Method: We systematically searched Embase, PubMed, cochrane library, Ovid MEDLINE, Scopus, Web of Science from inception through April 2025, and meta-analysis using RevMan5.4.1. Eligible studies were randomized control trials (RCTs) comparing RIC plus IVT versus IVT with control in patients with AIS. primary outcomes were 90 days modified Rankin Scale (mRS) scores 0–1 and 0–2, stroke recurrence and all-cause mortality. Secondary outcomes hemorrhagic transformation of infarction (HTI), Barthel Index, and NIHSS scores at multiple time points. Random-effects models were used to estimate pooled risk ratios (RR) or mean differences (MD) with 95% confidence intervals (CI) and heterogeneity was assessed with the I2 statistic. Result: From six studies, a total of 955 patients were included (remote ischemic conditioning [RIC] group: n = 502; sham/control group: n = 453). At 90 days, RIC was not associated with improved functional outcomes: mRS 0–1 (4 studies; RR 1.07, 95% CI 0.95–1.20; p = 0.26; I2 = 17%) or mRS 0–2 (4 studies; RR 1.03, 95% CI 0.89–1.03; p = 0.92; I2 = 64%). Stroke recurrence (4 studies; RR 1.04, 95% CI 0.67–1.59; p = 0.87; I2 = 0%), mortality (3 studies; RR 0.91, 95% CI 0.27–3.06; p = 0.87; I2 = 46%), HTI (3 studies; RR 1.12, 95% CI 0.59–2.11; p = 0.74; I2 = 0%), and Barthel Index (3 studies; MD 2.77, 95% CI –1.51 to 7.06; p = 0.20; I2 = 0%) showed no significant benefit with RIC. NIHSS scores were also comparable at 24 hours (2 studies; MD –0.28, 95% CI –0.84 to 0.27; p = 0.32), 7 days (3 studies; MD 0.01, 95% CI –0.49 to 0.50; p = 0.97), 30 days (2 studies; MD –0.63, 95% CI –1.38 to 0.12; p = 0.10), and last follow-up last follow-up (4 studies; MD –0.08, 95% CI –0.43 to 0.28; p = 0.67), all with I2 = 0%. Conclusion: This meta-analysis suggests patients with acute ischemic stroke treated with intravenous thrombolysis and remote ischemic conditioning (RIC) did not significantly improve functional outcomes, reduce stroke recurrence, mortality, or hemorrhagic transformation. No meaningful differences were observed in neurological recovery or activities of daily living.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (11)

Y

Yousif Kurmasha

College of Medicine, university of Kufa, Najaf, Iraq

M

Mohamed wagdy

K

khadeeja Hamzah

Baghdad University AIkindy College, Baghdad , Iraq

Y

Yasser Almealawy

Faculty of Medicine, University of Kufa, Kufa, Iraq

M

Mohammedsadeq A. Shweliya

Baghdad University, Baghdad , Iraq

A

Abdulrahman Raad Abdulkareem Al-waeli

al-karkh General hospital, Baghdad, Iraq

A

Abubaker Alghazal

Faculty of medicine, University of Benghazi, Benghazi, Libya

M

Mohamed Morshed

The Faculty of Medicine Mansoura University, Mansoura, Egypt

Z

Zahraa Ali

Baghdad University, Baghdad , Iraq

A

Ali Saad Al-Shammari

University of Baghdad, Baghdad, Iraq

M

Mohammed Kirmasha

Tehran university of medical science, Tehran, Iran (the Islamic Republic of)